MYMETHAZINE FORTIS Drug Patent Profile
Which patents cover Mymethazine Fortis, and what generic alternatives are available?
Mymethazine Fortis is a drug marketed by Usl Pharma and is included in one NDA.
The generic ingredient in MYMETHAZINE FORTIS is promethazine hydrochloride. There is one drug master file entry for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the promethazine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mymethazine Fortis
A generic version of MYMETHAZINE FORTIS was approved as promethazine hydrochloride by ZYDUS PHARMS USA on November 18th, 2005.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MYMETHAZINE FORTIS?
- What are the global sales for MYMETHAZINE FORTIS?
- What is Average Wholesale Price for MYMETHAZINE FORTIS?
Summary for MYMETHAZINE FORTIS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 110 |
| Patent Applications: | 2,749 |
| DailyMed Link: | MYMETHAZINE FORTIS at DailyMed |
US Patents and Regulatory Information for MYMETHAZINE FORTIS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Usl Pharma | MYMETHAZINE FORTIS | promethazine hydrochloride | SYRUP;ORAL | 087996-001 | Jan 18, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |

